Monday, July 23, 2018
An Interesting Interim Analysis for Bellerophon is Imminent.
This blog post was being written to discuss the interim analysis of Bellerophon Therepeutic's (BLPH) phase 3 INOvation-1 clinical trial for pulmonary arterial hypertension. While I was still drafting it, the company announced that the trial was being stopped for futility. As a result this blog post was not completed.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment